Resistant “Candidal Intertrigo”: Could Inverse Psoriasis Be the True Culprit?

References

1. 1.↵
   1. Habif TP

   ed. Skin Disease, Diagnosis and Treatment. 3rd ed. Philadelphia: Elsevier Saunders; 2011.
2. 2.↵
   1. Wang G,
   2. Li C,
   3. Gao T,
   4. Liu Y

   . Clinical analysis of 48 cases of inverse psoriasis: a hospital-based study. Eur J Dermatol 2005;15:176–8.

   OpenUrlPubMed
3. 3.↵
   1. Seyhan M,
   2. Coskun BK,
   3. Saglam H,
   4. Ozcan H,
   5. Karincaoglu Y

   . Psoriasis in childhood and adolescence: evaluation of demographic and clinical features. Pediatr Int 2006;48:525–30.

   OpenUrlPubMed
4. 4.↵
   1. Kundakci N,
   2. Tursen U,
   3. Babiker MO,
   4. Gurgey E

   . The evaluation of the sociodemographic and clinical features of Turkish psoriasis patients. Int J Dermatol 2002;41:220–4.

   OpenUrlCrossRefPubMedWeb of Science
5. 5.↵
   1. Dubertret L,
   2. Mrowietz U,
   3. Ranki A,
   4. et al

   ; EUROPSO Patient Survey Group. European patient perspectives on the impact of psoriasis: the EUROPSO patient membership survey. Br J Dermatol 2006;155:729–36.

   OpenUrlCrossRefPubMed
6. 6.↵
   1. Lisi P

   . Differential diagnosis of psoriasis. Reumatismo 2007; 59 (Suppl 1): 56– 60.

   OpenUrlPubMed
7. 7.↵
   1. van de,
   2. Kerkhof PC,
   3. Murphy GM,
   4. Austad J,
   5. Ljungberg A,
   6. Cambazard F,
   7. Duvold LB

   . Psoriasis of the face and flexures. J Dermatolog Treat 2007;18:351–60.

   OpenUrlCrossRefPubMed
8. 8.↵
   1. Chen JF,
   2. Liu YC,
   3. Wang WM

   . Dermacase. Can you identify this condition? Inverse psoriasis. Can Fam Physician 2011;57:903–4.

   OpenUrlFREE Full Text
9. 9.↵
   1. Janniger CK,
   2. Schwartz RA,
   3. Szepietowski JC,
   4. Reich A

   . Intertrigo and common secondary skin infections. Am Fam Physician 2005;72:833–8.

   OpenUrlPubMedWeb of Science
10. 10.↵
    1. Ayala F

    . Clinical presentation of psoriasis. Reumatismo 2007; 59 (Suppl 1): 40– 5.

    OpenUrlPubMed
11. 11.↵
    1. Wolff K,
    2. Johnson R

    eds. Fitzpatrick's Color Atlas and Synopsis of Clinical Dermatology. 6th ed. New York: McGraw-Hill; 2009.
12. 12.↵
    1. Leibovici V,
    2. Alkalay R,
    3. Hershko K,
    4. et al

    . Prevalence of Candida on the tongue and intertriginous areas of psoriatic and atopic dermatitis patients. Mycoses 2008;51:63–6.

    OpenUrlPubMed
13. 13.↵
    1. Flytstrom I,
    2. Bergbrant IM,
    3. Brared J,
    4. Brandberg LL

    . Microorganisms in intertriginous psoriasis: no evidence of Candida. Acta Derm Venereol 2003;83:121–3.

    OpenUrlPubMed
14. 14.↵
    1. Fry L,
    2. Baker BS

    . Triggering psoriasis: the role of infections and medications. Clin Dermatol 2007;25:606–15.

    OpenUrlCrossRefPubMedWeb of Science
15. 15.↵
    1. Andrews MD,
    2. Burns M

    . Common tinea infections in children. Am Fam Physician 2008;77:1415–20.

    OpenUrlPubMedWeb of Science
16. 16.↵
    1. Marks JG Jr.,
    2. Miller JJ

    eds. Lookingbill and Marks' Principles of Dermatology. 4th ed. Philadelphia: Saunders Elsevier; 2006.
17. 17.↵
    1. Fleischer AB Jr.

    . Diagnosis and management of common dermatoses in children: atopic, seborrheic, and contact dermatitis. Clin Pediatr (Phila) 2008;47:332–46.

    OpenUrlAbstract/FREE Full Text
18. 18.↵
    1. Gupta AK,
    2. Bluhm R

    . Seborrheic dermatitis. J Eur Acad Dermatol Venereol 2004; 18: 13– 26; quiz 19–20.

    OpenUrlCrossRefPubMedWeb of Science
19. 19.↵
    1. De Rosa G,
    2. Mignogna C

    . The histopathology of psoriasis. Reumatismo 2007; 59 (Suppl 1): 46– 8.

    OpenUrlPubMed
20. 20.↵
    1. Syed ZU,
    2. Khachemoune A

    . Inverse psoriasis: case presentation and review. Am J Clin Dermatol 2011;12:143–6.

    OpenUrlPubMed
21. 21.↵
    1. Kalb RE,
    2. Bagel J,
    3. Korman NJ,
    4. et al

    . Treatment of intertriginous psoriasis: from the Medical Board of the National Psoriasis Foundation. J Am Acad Dermatol 2009;60:120–4.

    OpenUrlCrossRefPubMedWeb of Science
22. 22.↵
    1. Saber M,
    2. Brassard D,
    3. Benohanian A

    . Inverse psoriasis and hyperhidrosis of the axillae responding to botulinum toxin type A. Arch Dermatol 2011;147:629–30.

    OpenUrlCrossRefPubMed
23. 23.↵
    1. Zanchi M,
    2. Favot F,
    3. Bizzarini M,
    4. Donini M,
    5. Sedona P

    . Botulinum toxin type-A for the treatment of inverse psoriasis. J Eur Acad Dermatol Venereol 2008;22:431–6.

    OpenUrlCrossRefPubMedWeb of Science
24. 24.↵
    1. George D,
    2. Rosen T

    . Treatment of inverse psoriasis with efalizumab. J Drugs Dermatol 2009; 8: 74– 6.

    OpenUrlPubMed